Antoine A.
- Country
- France
- Department
- Medical Oncology
Research Overview
- Phase 3 Study of LY4170156 (Sofetabart Mipitecan) ± Bevacizumab versus standard chemotherapy in platinum‑resistant and platinum‑sensitive ovarian cancer
- Phase 3 Randomized Open-Label Trial of Tisotumab Vedotin Versus Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
- Phase III Randomized Trial of Platinum-Based Chemotherapy with Paclitaxel, Bevacizumab, and Atezolizumab in Metastatic, Persistent, or Recurrent Cervical Carcinoma
Data & Insights
Has run more than one trial at 155 of 303 partner sites.
Specializations
Gynecologic Oncology
The investigator specializes in treating various forms of gynecologic cancers, with particular emphasis on ovarian cancer and its variants, including high-grade serous and endometrioid types.
- Primary Peritoneal Cancer
- Fallopian Tube Cancer
- Advanced Epithelial Ovarian Cancer
Their research extends to both platinum-resistant and platinum-sensitive disease states.
Cervical Cancer Research
The investigator focuses on developing treatments for cervical cancer across various stages, from locally advanced to metastatic disease.
- Squamous Cell Carcinoma
- Adenosquamous Carcinoma
- Recurrent Cervical Cancer
Special attention is given to innovative therapeutic approaches for advanced-stage disease.
Endometrial Cancer Studies
The investigator conducts research in endometrial cancer treatment, with particular focus on advanced and recurrent cases.
- MMR Deficient Endometrial Cancer
- Metastatic Endometrial Cancer
- Carcinosarcoma
Their work encompasses both early-stage disease and advanced metastatic settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.